Circulating Interleukin-22 Is a Biomarker for Newly Diagnosed Type 2 Diabetes Mellitus and Associated with Hypoglycemic Effect of Sitagliptin
Peiye Sun,* Yuxi Xiao,* Yuan Dong, Yixiang Feng, Hongting Zheng, Xiaoyu Liao Department of Endocrinology, Translational Research of Diabetes Key Laboratory of Chongqing Education Commission of China, the second Affiliated Hospital of Army Medical University, Chongqing, People’s Repub...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity |
| Subjects: | |
| Online Access: | https://www.dovepress.com/circulating-interleukin-22-is-a-biomarker-for-newly-diagnosed-type-2-d-peer-reviewed-fulltext-article-DMSO |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|